01 5Saphris
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 155
2016 Revenue in Millions : 167
Growth (%) : -7
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 140
2017 Revenue in Millions : 155
Growth (%) : -10%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 167
2015 Revenue in Millions : 187
Growth (%) : -11
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 135
2018 Revenue in Millions : 140
Growth (%) : -3
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions :
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?